TVTX

Travere Therapeutics, Inc. Common Stock
Data: 2026-08-21

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Quick Stats
Aug 21, 2026

35.9

AI Score

EXTENDED

1.07

Volume Ratio

TBA

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

TVTX Stock Summary

Last updated Aug 21, 2026

TVTX is currently trading at $65.71, positioned above its 200-day moving average of $40.82, indicating a long-term uptrend. The stock has a 52-week range of $17.05 to $66.38.

Technical Analysis: The 50-day moving average stands at $57.9, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 67.24, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.148, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TVTX at 35.9/100 with a EXTENDED recommendation.

TVTX (Travere Therapeutics, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 67.24
CMF (20) -0.148
ROC (10) 7.159
ADX (14) 30.837
Indicator Value
MACD (12,26,9) 2.428
AROONOSC (14) 100.0
WILLAMS %R (14) -5.51
MFI (14) 72.005
TVTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

TVTX Price vs Max Options Open Interest
TVTX Max Change In Options Open Interest

TVTX Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

TVTX Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

TVTX Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

TVTX Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Travere Therapeutics, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.

TVTX Moving Averages Analysis

Travere Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

Travere Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

TVTX (Travere Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 63.04
20 60.46
30 59.12
50 57.9
100 49.54
200 40.82

TVTX Fundamental Analysis

P/E (Forward) 76.3359
P/E (Trailing) --
Market Cap ($) 6.0 billion
Earnings/Share ($) -0.72
Net Profit Margin (%) -0.0735
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.7353
EPS Estimate Next Year ($) 5.6724
WallStreet Target Price ($) 74.14
Most Recent Quarter